Thor Alvegård

affiliated with the university
More filtering options
  1. 2020
  2. Survival Outcomes Associated with 3 Years vs 1 Year of Adjuvant Imatinib for Patients with High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial after 10-Year Follow-up

    Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, Annette Reichardt, Barbara Hermes, Jochen Schütte, Silke Cameron, Peter Hohenberger, Philipp J. Jost, Salah Eddin Al-Batran, Lars H. Lindner, Sebastian Bauer, Eva Wardelmann, Bengt Nilsson, Raija Kallio, Panu Jaakkola, Jouni Junnila, Thor Alvegård & Peter Reichardt, 2020, In : JAMA oncology. 6, 8, p. 1241-1246 6 p.

    Research output: Contribution to journalArticle

  3. 2017
  4. The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma

    Clement Trovik, Henrik C F Bauer, Emelie Styring, Kirsten Sundby Hall, Fredrik Vult Von Steyern, Sigvard Eriksson, Ingela Johansson, Mika Sampo, Minna Laitinen, Anders Kalén, Halldór Jónsson, Nina L Jebsen, Mikael Eriksson, Erkki Tukiainen, Najme Wall, Olga Zaikova, Helgi Sigurðsson, Tuula Lehtinen, Bodil Bjerkehagen, Mikael Skorpil & 3 others, Geir Egil Eide, Elisabeth Johansson & Thor A. Alvegard, 2017 Mar 7, In : Acta Orthopaedica. 88, 3, p. 341-347

    Research output: Contribution to journalArticle

  5. 2016
  6. Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.

    Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, Annette Reichardt, Jörg T Hartmann, Daniel Pink, Giuliano Ramadori, Peter Hohenberger, Salah-Eddin Al-Batran, Marcus Schlemmer, Sebastian Bauer, Eva Wardelmann, Bengt Nilsson, Harri Sihto, Petri Bono, Raija Kallio, Jouni Junnila, Thor Alvegård & Peter Reichardt, 2016, In : Journal of Clinical Oncology. 34, 3, p. 244-250

    Research output: Contribution to journalArticle

  7. Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour - Does it increase the risk for tumour cell seeding and recurrence?

    Mikael Eriksson, Peter Reichardt, Kirsten Sundby Hall, Jochen Schütte, Silke Cameron, Peter Hohenberger, Sebastian Bauer, Mika Leinonen, Annette Reichardt, Maria Rejmyr Davis, Thor Alvegård & Heikki Joensuu, 2016, In : European Journal of Cancer. 59, p. 128-133 6 p.

    Research output: Contribution to journalArticle

  8. 2014
  9. 2012
  10. One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor: A Randomized Trial

    Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, Joerg T. Hartmann, Daniel Pink, Jochen Schuette, Giuliano Ramadori, Peter Hohenberger, Justus Duyster, Salah-Eddin Al-Batran, Marcus Schlemmer, Sebastian Bauer, Eva Wardelmann, Maarit Sarlomo-Rikala, Bengt Nilsson, Harri Sihto, Odd R. Monge, Petri Bono, Raija Kallio, Aki Vehtari & 3 others, Mika Leinonen, Thor Alvegård & Peter Reichardt, 2012, In : JAMA: The Journal of the American Medical Association. 307, 12, p. 1265-1272

    Research output: Contribution to journalArticle

  11. 2011
  12. Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol

    S. Ferrari, K. Sundby Hall, R. Luksch, A. Tienghi, Thomas Wiebe, F. Fagioli, Thor Alvegård, A. Brach del Prever, A. Tamburini, M. Alberghini, L. Gandola, M. Mercuri, R. Capanna, S. Mapelli, A. Prete, M. Carli, P. Picci, E. Barbieri, G. Bacci & S. Smeland, 2011, In : Annals of Oncology. 22, 5, p. 1221-1227

    Research output: Contribution to journalArticle

  13. Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma 63 patients with a minimum follow-up of 4 years

    Sigbjorn Smeland, Oyvind S. Bruland, Lars Hjorth, Otte Brosjo, Bodil Bjerkehagen, Gustaf Osterlundh, Ake Jakobson, Kirsten Sundby Hall, Odd R. Monge, Olle Bjork & Thor Alvegård, 2011, In : Acta Orthopaedica. 82, 2, p. 211-216

    Research output: Contribution to journalArticle

  14. 2009
  15. Scandinavian experience in classical osteosarcoma Results of the SSG XIV protocol

    Sigbjorn Smeland, Oyvind S. Bruland, Lars Hjorth, Otte Brosjo, Bodil Bjerkehagen, Gustaf Osterlundh, Ake Jakobson, Kirsten Sundby Hall, Odd R. Monge, Olle Bjork & Thor Alvegård, 2009, In : Acta Orthopaedica. 80, p. 60-66

    Research output: Contribution to journalArticle

  16. The European postmarketing adult Osteosarcoma Surveillance Study: characteristics of patients A preliminary report

    Birgitta von Scheele, Rebecca D. Martin, Alicia W. Gilsenan, Jeanette Ceberg, Elizabeth B. Andrews, Daniel Masica & Thor Alvegård, 2009, In : Acta Orthopaedica. 80, p. 67-74

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 Next